Tick-borne infections in the United States

Primary Care - Clinics in Office Practice

Volumn 40, Issue 3, 2013, Pages 619-635

  Pujalte, George G A ^a   Chua, Joel V ^b,c  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b Infusion Solutions of Delaware   (United States)

^c Kent General Hospital   (United States)

Author keywords

Babesiosis; Ehrlichiosis; Lyme; Spirochetes; Tick borne; Ticks; Tularemia

Indexed keywords

AMOXICILLIN; ANTIPYRETIC AGENT; ATOVAQUONE; AZITHROMYCIN; CEFTRIAXONE; CEFUROXIME; CEFUROXIME AXETIL; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; LYME DISEASE VACCINE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; QUININE; STEROID; STREPTOMYCIN; TETRACYCLINE;

AMBLYOMMA AMERICANUM; BABESIA DIVERGENS; BABESIA MICROTI; BED NET; BORRELIA BURGDORFERI; BORRELIA HERMSII; COLORADO TICK FEVER; DERMACENTOR VARIABILIS; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EXCHANGE BLOOD TRANSFUSION; FLU LIKE SYNDROME; FRANCISELLA TULARENSIS; HERXHEIMER REACTION; HUMAN; HUMAN GRANULOCYTIC ANAPLASMOSIS; HUMAN MONOCYTIC EHRLICHIOSIS; IMMUNOFLUORESCENCE; INFECTION PREVENTION; IXODES; LYME DISEASE; MEDICAL HISTORY; MORBIDITY; MORTALITY; ORNITHODOROS; PARASITE TRANSMISSION; PHYSICAL EXAMINATION; PIROPLASMOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; ROCKY MOUNTAIN SPOTTED FEVER; SUMMER; THORAX RADIOGRAPHY; TICK BITE; TICK BORNE DISEASE; TICK BORNE RELAPSING FEVER; TULAREMIA; VACCINATION; WESTERN BLOTTING;

BABESIOSIS; EHRLICHIOSIS; LYME; SPIROCHETES; TICK-BORNE; TICKS; TULAREMIA;

ANTI-BACTERIAL AGENTS; CLOTHING; HUMANS; INSECT REPELLENTS; INSECTICIDE-TREATED BEDNETS; PRIMARY HEALTH CARE; RISK FACTORS; TICK CONTROL; TICK-BORNE DISEASES; UNITED STATES;

EID: 84882276683     PISSN: 00954543     EISSN: 1558299X     Source Type: Journal    
DOI: 10.1016/j.pop.2013.05.003     Document Type: Review

References (53)

1. Bratton R.L., Corey G.R. Tick-borne disease. Am Fam Physician 2005, 71:2323-2330. 2331-2.
2. Gayle A., Ringdahl E. Tick-borne diseases. Am Fam Physician 2001, 64:461-466.
3. Piesman J., Eisen L. Prevention of tick-borne diseases. Annu Rev Entomol 2008, 53:323-343.
4. Raoult D., Fournier P.E., Eremeeva M., et al. Naming of rickettsiae and rickettsial diseases. Ann N Y Acad Sci 2005, 1063:1-12.
5. Mandl C.W. Steps of the tick-borne encephalitis virus replication cycle that affect neuropathogenesis. Virus Res 2005, 111:161-174.
6. Ellis J., Oyston P.C., Green M., et al. Tularemia. Clin Microbiol Rev 2002, 15:631-646.
7. Goddard J. Tick-borne diseases. Infectious diseases and arthropods 2008, 81-129. Humana Press, Totowa (NJ). 2nd edition. V.S. Georgiev (Ed.).
8. Centers for Disease Control and Prevention. Tick-borne relapsing fever. Available at: Accessed March 16, 2013. http://www.cdc.gov/relapsing-fever/clinicians/#treatment.
9. Kazzi MG. Colorado tick fever. In: Kulkarni R, editor. Medscape. Available at: Accessed March 16, 2013. http://emedicine.medscape.com/article/786688-medication.
10. Centers for Disease Control and Prevention. Parasites: babesiosis. Available at: Accessed March 16, 2013. http://www.cdc.gov/parasites/babesiosis/health_professionals/index.html#tx.
11. Diaz J.H. Ticks, including tick paralysis. Mandell, Douglas, and Bennett's principles and practice of infectious diseases 2010, 3649-3662. Elsevier Churchill Livingstone, Philadelphia. 7th edition. G.L. Mandell, J.E. Bennett, R. Dolin (Eds.).
12. Centers for Disease Control and Prevention. Abstract: Consensus statement: tularemia as a biological weapon: medical and public health management.Available at: Accessed March 16, 2013. http://www.bt.cdc.gov/agent/tularemia/tularemia-biological-weapon-abstract.asp#4.
13. Cunha BA. Ehrlichiosis. In: Bronze M, editor. Medscape. Available at: Accessed March 16, 2013. http://emedicine.medscape.com/article/235839-medication.
14. Wormser G.P., Dattwyler R.J., Shapiro E.D., et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006, 43:1089-1134.
15. Centers for Disease Control and Prevention. Rocky Mountain spotted fever (RMSF). Available at: Accessed March 16, 2013. http://www.cdc.gov/rmsf/symptoms/index.html.
16. Steve A.C. Lyme borreliosis. Harrison's manual of medicine 2005, 995-999. McGraw-Hill, New York. 16th edition. D.L. Kasper, T.R. Harrison (Eds.).
17. Gilbert DN, Moellering RC, Eliopoulos GM, et al. Antimicrobial therapy. TheSanford guide to antimicrobial therapy. 34th edition. Hyde Park (VT): Blackwell Publishing; 2004. p. 39.
18. Byrd R.P., Vasquez J., Roy T.M. Respiratory manifestations of tick-borne diseases in the southeastern United States. South Med J 1997, 90:1-4.
19. Emmons R.W. An overview of Colorado tick fever. Prog Clin Biol Res 1985, 178:47-52.
20. Drugs for parasitic infections. Med Lett Drugs Ther, 2010. Available at: Accessed February 17, 2013. http://secure.medicalletter.org/system/files/private/parasitic.pdf.
21. Evans M.E., Gregory D.W., Schaffner W., et al. Tularemia: a 30-year experience with 88 cases. Medicine 1985, 64:251-269.
22. Miller R.P., Bates J.H. Pleuropulmonary tularemia: a review of 29 patients. Am Rev Respir Dis 1969, 99:31-41.
23. Rubin S.A. Radiographic spectrum of pleuropulmonary tularemia. Am J Roentgenol 1978, 131:277-281.
24. Dennis D.T., Inglesby T.V., Henderson D.A., et al. Tularemia as a biological weapon: medical and public health management. JAMA 2001, 285:2763-2773.
25. Beers M.H., Berkow R. The Merck manual of diagnosis and therapy 1999, Merck Research Laboratories, Whitehouse Station (NJ). 17th edition.
26. Dumler J.S., Walker D.H. Ehrlichia chaffeensis (human monocytotropic ehrlichiosis), Anaplasma phagocytophilum (human granulocytotropic anaplasmosis), and other Anaplasmataceae. Mandell, Douglas, and Bennett's principles and practice of infectious diseases 2010, 2531-2538. Elsevier Churchill Livingstone, Philadelphia. 7th edition. G.L. Mandell, J.E. Bennett, R. Dolin (Eds.).
27. Belman A.L. Tick-borne diseases. Semin Pediatr Neurol 1999, 6:249-266.
28. Centers for Disease Control and Prevention. Human ehrlichiosis in the United States. Available at: Accessed February 19, 2013. http://gov/ncidod/dvrd/ehrlichia/index.htm.
29. Shapiro E.D. Tick-borne diseases. Adv Pediatr Infect Dis 1997, 13:187-218.
30. Piesman J., Mather T.N., Sinsky R.J., et al. Duration of tick attachment and Borrelia burgdorferi transmission. JClin Microbiol 1987, 25:557-558.
31. Piesman J., Maupin G.O., Campos E.G., et al. Duration of adult female Ixodes dammini attachment and transmission of Borrelia burgdorferi, with description of a needle aspiration isolation method. JInfect Dis 1991, 163:895-897.
32. Piesman J. Dynamics of Borrelia burgdorferi transmission by nymphal Ixodes dammini ticks. JInfect Dis 1993, 167:1082-1085.
33. Falco R.C., Fish D., Piesman J. Duration of tick bites in a Lyme disease endemic area. Am J Epidemiol 1996, 143:187-192.
34. Centers for Disease Control and Prevention. Lyme disease. Available at: Accessed February 20, 2013. http://www.cdc.gov/lyme/.
35. Bacon R.M., Biggerstaff B.J., Schriefer M.E., et al. Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. JInfect Dis 2003, 187(8):1187-1199.
36. Magid D., Schwartz B., Craft J., et al. Prevention of Lyme disease after tick bites: a cost-effectiveness analysis. NEngl J Med 1992, 327:534-541.
37. Treatment of Lyme disease. Med Lett Drugs Ther 2000, 42:37-39.
38. Centers for Disease Control and Prevention Provisional cases of selected notifiable diseases, week ending December 29, 2007. MMWR Morb Mortal Wkly Rep 2008, 56:1360-1371.
39. Walker D.H. Tick-transmitted infectious diseases in the United States. Annu Rev Public Health 1998, 19:237-269.
40. Kwitkowski V.E., Demko S.G. Infectious disease emergencies in primary care. Lippincotts Prim Care Pract 1999, 3:108-125.
41. Thorner A.R., Walker D.H., Petri W.A. Rocky Mountain spotted fever. Clin Infect Dis 1998, 27:1353-1359.
42. Gardulf A., Wohlfart I., Gustafson R. Aprospective cross-over field trial shows protection of lemon eucalyptus extract against tick bites. JMed Entomol 2004, 41:1064-1067.
43. Dietrich G., Dolan M.C., Peralta-Cruz J., et al. Repellent activity of fractioned compounds from Chamaecyparis nootkatensis essential oil against nymphal Ixodes scapularis (Acari: Ixodidae). JMed Entomol 2006, 43:957-961.
44. Jaenson T.G., Garboui S., Palsson K. Repellency of oils of lemon eucalyptus geranium, and lavender and the mosquito repellent MyggA natural to Ixodes ricinus (Acari: Ixodidae) in the laboratory and field. JMed Entomol 2006, 43:731-736.
45. Gammons M., Salam G. Tick removal. Am Fam Physician 2002, 66:643-645.
46. Schulze T.L., Jordan R.A., Hung R.W., et al. Efficacy of granular deltamethrin against Ixodes scapularis and Amblyomma americanum (Acari: Ixodidae) nymphs. JMed Entomol 2001, 38:344-346.
47. Steere A.C., Sikand V.K., Meurice F., et al. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. NEngl J Med 1998, 339:209-215.
48. Poland G.A. Vaccines against Lyme disease: what happened and what lessons can we learn?. Clin Infect Dis 2011, 52(Suppl 3):s253-s258.
49. Maupin G.O., Fish D., Zultowsky J., et al. Landscape ecology of Lyme disease in a residential area of Westchester County, New York, USA. Am J Epidemiol 1991, 133:1105-1113.
50. Piesman J. Response of nymphal Ixodes scapularis, the primary tick vector of Lyme disease spirochetes in North America, to barriers derived from wood products or related home and garden items. JVector Ecol 2006, 31:412-417.
51. Schulze T.L., Jordan R.A., Hung R.W. Suppression of subadult Ixodes scapularis (Acari: Ixodidae) following removal of leaf litter. JMed Entomol 1995, 32:730-733.
52. Walker D.H., Barbour A.G., Oliver J.H., et al. Emerging bacterial zoonotic and vector-borne diseases: ecological and epidemiological factors. JAMA 1996, 275:463-469.
53. Meldrum S.C., Birkhead G.S., White D.J., et al. Human babesiosis in New York state: an epidemiological description of 136 cases. Clin Infect Dis 1992, 15:1019-1023.